PARC: A Phase I / II study evaluating the activity of Pegylated recombinant human Arginase (BCT-100) in RElapsed/refractory Cancers of childhood

Mussai, Francis (Principal Investigator)
Beggs, Andrew (Co-Investigator)
Fenwick, Nicola (Co-Investigator)
Wheatley, Keith (Co-Investigator)
De Santo, Carmela (Co-Investigator)
Kearns, Pamela (Co-Investigator)
Slade, Daniel (Co-Investigator)

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science